3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Platinum-resistant Ovarian Cancer
1
Neoplasms
1
Hematologic Neoplasms
1
Interventions
anlotinib
2
niraparib
1
afuresertib
1
Paclitaxel
1
Gemcitabine
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Platinum-resistant Ovarian Cancer
×
afuresertib
×
Clear all
NCT04374630
2025-09-10
PROFECTA-II
Laekna Limited
Phase 2
Completed
150 enrolled